Gilead Licenses Remdesivir To Five Firms

Cipla, Ferozsons, Hetero, Jubilant And Mylan Get Rights

 
• By David Wallace
  
Gilead
Gilead has struck licensing deals with five generics firms for remdesivir • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business